Literature DB >> 21772296

Chronic calcineurin inhibitor use is nephrotoxic.

J R Chapman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21772296     DOI： 10.1038/clpt.2011.117

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  4 in total

1.  Lessons Learned: Early Termination of a Randomized Trial of Calcineurin Inhibitor and Corticosteroid Avoidance Using Belatacept.

Authors:  K A Newell; A K Mehta; C P Larsen; P G Stock; A B Farris; S G Mehta; D Ikle; B Armstrong; Y Morrison; N Bridges; M Robien; R B Mannon
Journal:  Am J Transplant       Date:  2017-07-03       Impact factor: 8.086

Review 2.  The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Authors:  Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

3.  Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial.

Authors:  Stephan Busque; Flavio G Vincenti; Helio Tedesco Silva; Philip J O'Connell; Atsushi Yoshida; John J Friedewald; Steven M Steinberg; Klemens Budde; Emine N Broeders; Yon Su Kim; Carolyn M Hahn; Huihua Li; Gary Chan
Journal:  Transplant Direct       Date:  2018-08-08

4.  Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.

Authors:  Rahul Bohra; Wenzel Schöning; Jelena Klawitter; Nina Brunner; Volker Schmitz; Touraj Shokati; Ryan Lawrence; Maria Fernanda Arbelaez; Björn Schniedewind; Uwe Christians; Jost Klawitter
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.